Showing results (11-20 of 103) with videos related to
Sort By:
Pageof 11
Endocrine-Related Cancer|July 13, 2021
Tailoring the approach to radioactive iodine treatment in thyroid cancerSarah E Mayson, Christine M Chan, Bryan R HaugenMolecular Cancer|May 25, 2010
Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasionKevin T Bauerle, Rebecca E Schweppe, Bryan R HaugenPPAR Research|October 28, 2009
Combination PPARgamma and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2Joshua P Klopper, Vibha Sharma, Reid Bissonnette, et al.Clinical Endocrinology|May 24, 2018
Outcomes of Bethesda categories III and IV thyroid nodules over 5 years and performance of the Afirma gene expression classifier: A single-institution studyKelsi E Deaver, Bryan R Haugen, Nikita Pozdeyev, et al.Clinical Nuclear Medicine|June 26, 2013
SPECT/CT of metastatic struma ovariiPhillip J Koo, William C Klingensmith, Brian M Bagrosky, et al.Thyroid : Official Journal of the American Thyroid Association|February 13, 2002
Clinical comparison of whole-body radioiodine scan and serum thyroglobulin after stimulation with recombinant human thyrotropinBryan R Haugen, E Chester Ridgway, Beverly A McLaughlin, et al.The Lancet. Diabetes & Endocrinology|October 25, 2016
Leveraging the immune system to treat advanced thyroid cancersJena D French, Keith Bible, Christine Spitzweg, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 17, 2010
Adverse event reporting in patients treated with levothyroxine: results of the pharmacovigilance task force survey of the american thyroid association, american association of clinical endocrinologists, and the endocrine societyJames V Hennessey, Alan O Malabanan, Bryan R Haugen, et al.The Journal of Clinical Endocrinology and Metabolism|September 25, 2025
Artificial intelligence applications in thyroid cancer careNikita Pozdeyev, Samantha L White, Caitlin C Bell, et al.Human Pathology|July 3, 2002
Excessive survivin expression in thyroid lymphomasMasahiro Sugawara, Fumio Matsuzuka, Shuji Fukata, et al.Pageof 11